We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
+13.07%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$7.34M
(+9.2%)
Cap. Flow
+$584K
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
132
New
15
Increased
19
Reduced
50
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.1M |
| 2 |
SNAK
Inventure Foods, Inc.
SNAK
|
+$947K |
| 3 |
VYNT
Vyant Bio, Inc. Common Stock
VYNT
|
+$929K |
| 4 |
H.B. Fuller
FUL
|
+$839K |
| 5 |
CTLP
Cantaloupe
CTLP
|
+$779K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSPH
NANOSPHERE INC. COM NEW
NSPH
|
+$1.56M |
| 2 |
STJ
St Jude Medical
STJ
|
+$1.37M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$1.25M |
| 4 |
Fastenal
FAST
|
+$1.22M |
| 5 |
Bank of America
BAC
|
+$675K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.77% |
| 2 | Technology | 11.04% |
| 3 | Industrials | 7.97% |
| 4 | Consumer Staples | 5.57% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$448B
| $1.08M | 1.24% |
17,475
-1,000
| -5% | -$60.9K |
|
|
CAB
27
DELISTED
Cabela's Inc
CAB
| $1.08M | 1.23% |
21,500
+1,750
| +9% | +$87.1K |
|
28
CVS Health
CVS
$137B
| $1.07M | 1.23% |
11,183
-1,000
| -8% | -$99.7K |
|
29
Aflac
AFL
$63.2B
| $1.03M | 1.18% |
28,600
-1,500
| -5% | -$51.2K |
|
30
Abbott
ABT
$177B
| $1.02M | 1.18% |
26,075
+1,900
| +8% | +$75.6K |
|
|
CTLP
31
DELISTED
Cantaloupe
CTLP
| $1.02M | 1.17% |
238,400
+181,750
| +321% | +$779K |
|
32
SPS Commerce
SPSC
$2.41B
| $985K | 1.13% |
32,500
-1,500
| -4% | -$38.8K |
|
|
CGNT
33
DELISTED
Cogentix Medical, Inc.
CGNT
| $977K | 1.12% |
1,016,071
-25,190
| -2% | -$24.9K |
|
34
Medtronic
MDT
$107B
| $959K | 1.1% |
11,050
-500
| -4% | -$40.4K |
|
35
Microsoft
MSFT
$2.99T
| $959K | 1.1% |
18,735
| – | – |
|
36
Johnson Controls International
JCI
$85B
| $873K | 1% |
18,837
+477
| +3% | +$21K |
|
|
OUTR
37
DELISTED
OUTERWALL INC
OUTR
| $853K | 0.98% |
20,300
-650
| -3% | -$26.3K |
|
|
38
H.B. Fuller
FUL
$2.98B
| $823K | 0.94% |
+18,700
| New | +$839K |
|
39
CarParts.com
PRTS
$40.3M
| $820K | 0.94% |
20,760
-5,535
| -21% | -$192K |
|
40
J.M. Smucker
SJM
$12B
| $815K | 0.93% |
5,350
-600
| -10% | -$79.8K |
|
41
Plus Therapeutics
PSTV
$26.4M
| $811K | 0.93% |
2
+1
| +100% | +$597K |
|
42
Xtant Medical Holdings
XTNT
$63.1M
| $790K | 0.91% |
34,482
-1,499
| -4% | -$38.6K |
|
43
Stanley Black & Decker
SWK
$13.6B
| $779K | 0.89% |
7,000
-500
| -7% | -$55.6K |
|
44
Expeditors International
EXPD
$23.2B
| $696K | 0.8% |
14,200
-2,000
| -12% | -$97.1K |
|
45
Kimberly-Clark
KMB
$36B
| $687K | 0.79% |
5,000
-400
| -7% | -$52.3K |
|
46
NCR Voyix
VYX
$1.11B
| $654K | 0.75% |
38,387
| – | – |
|
|
STRR
47
DELISTED
Star Equity Holdings
STRR
| $646K | 0.74% |
2,510
-20
| -0.8% | -$5.29K |
|
48
AngioDynamics
ANGO
$567M
| $644K | 0.74% |
+44,850
| New | +$560K |
|
49
Verizon
VZ
$182B
| $605K | 0.69% |
10,830
+6,400
| +144% | +$332K |
|
50
GSK
GSK
$100B
| $592K | 0.68% |
10,920
-840
| -7% | -$44.3K |
|
Similar funds
EWL
ECM
HCA
CWM
SNPAM
TWM
ACL
FMI
Perkins Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Perkins Capital Management held 132 positions worth $87.2M, up 9.2% from $79.9M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management's Q2 2016 filing shows 15 new, 19 increased, 50 reduced and 15 closed positions. Its largest new stake was Boston Scientific: 50,650 shares worth $1.18M. The largest sale was NANOSPHERE INC. COM NEW, an estimated $1.56M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 56% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q2 2016 buy was Boston Scientific: 50,650 shares worth $1.18M.
- Perkins Capital Management added most to Inventure Foods, Inc. in Q2 2016, an estimated $947K increase.
- Perkins Capital Management's biggest Q2 2016 reduction was NANOSPHERE INC. COM NEW, cutting an estimated $1.56M.
- Perkins Capital Management fully exited HD Supply Holdings, Inc. in Q2 2016, selling an estimated $1.25M.
- Perkins Capital Management's ten largest holdings make up 35% of its $87.2M portfolio in Q2 2016.
- Perkins Capital Management opened 15 new positions and closed 15 in Q2 2016.
- Perkins Capital Management's portfolio value rose 9.2% quarter-over-quarter to $87.2M.
Based on Perkins Capital Management's 13F filing for Q2 2016, filed 20 Jul 2016.